Summit Therapeutics Inc. financial data

Symbol
SMMT on Nasdaq
Industry
Pharmaceutical Preparations
Location
2882 Sand Hill Road, Suite 106, Menlo Park, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Summit Therapeutics plc (to 9/17/2020), Summit Corp plc (to 1/30/2015)
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 298 % -80.1%
Debt-to-equity 126 % -19.2%
Return On Equity -155 % +66.7%
Return On Assets -68.8 % +62.3%
Operating Margin -268K % -6725%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 725M shares +3.85%
Common Stock, Shares, Outstanding 724M shares +3.82%
Entity Public Float 108M USD +322%
Common Stock, Value, Issued 7.24M USD +3.83%
Weighted Average Number of Shares Outstanding, Basic 708M shares +1.47%
Weighted Average Number of Shares Outstanding, Diluted 708M shares +1.47%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 80.5M USD +94.7%
General and Administrative Expense 42.7M USD +61.7%
Operating Income (Loss) -159M USD +73.1%
Nonoperating Income (Expense) -2.99M USD +60.3%
Net Income (Loss) Attributable to Parent -162M USD +72.9%
Earnings Per Share, Basic 0.31 USD/shares -350%
Earnings Per Share, Diluted 0.31 USD/shares -350%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.4M USD -32.5%
Cash, Cash Equivalents, and Short-term Investments 186M USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 181K USD -62.8%
Assets, Current 329M USD +44.5%
Property, Plant and Equipment, Net 223K USD -0.89%
Operating Lease, Right-of-Use Asset 8.72M USD +24.6%
Goodwill 1.88M USD -0.16%
Other Assets, Noncurrent 1.88M USD +640%
Assets 342M USD +44%
Accounts Payable, Current 3.34M USD +238%
Employee-related Liabilities, Current 4.88M USD +38.2%
Accrued Liabilities, Current 12.5M USD +222%
Contract with Customer, Liability, Current 0 USD
Liabilities, Current 140M USD +1075%
Contract with Customer, Liability, Noncurrent 0 USD
Operating Lease, Liability, Noncurrent 5.02M USD +15.8%
Other Liabilities, Noncurrent 1.6M USD +5.63%
Liabilities 147M USD +24.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.5M USD -2.54%
Retained Earnings (Accumulated Deficit) -1.1B USD -17.3%
Stockholders' Equity Attributable to Parent 195M USD +63.1%
Liabilities and Equity 342M USD +44%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.1M USD -129%
Net Cash Provided by (Used in) Financing Activities 485K USD -99.4%
Net Cash Provided by (Used in) Investing Activities 19.9M USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 724M shares +3.82%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.81M USD +98.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28.8M USD -31.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.5M USD +14.9%
Deferred Tax Assets, Valuation Allowance 84.8M USD +32.4%
Deferred Tax Assets, Gross 86M USD +32.5%
Operating Lease, Liability 6.1M USD +37%
Depreciation 27K USD -70%
Payments to Acquire Property, Plant, and Equipment 4K USD -92.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -162M USD +72.9%
Lessee, Operating Lease, Liability, to be Paid 6.59M USD +34.7%
Property, Plant and Equipment, Gross 1.25M USD -43.4%
Operating Lease, Liability, Current 3.69M USD +26%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.89M USD +92.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.81M USD +90.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +17.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 490K USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 893K USD -41.7%
Deferred Tax Assets, Operating Loss Carryforwards 59M USD +11.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 1.06M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Operating Lease, Payments 367K USD +23.6%
Additional Paid in Capital 1.29B USD +22.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 0 USD -100%
Share-based Payment Arrangement, Expense 30.1M USD +197%
Interest Expense 12.6M USD +5378%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%